2005
DOI: 10.1002/gcc.20178
|View full text |Cite
|
Sign up to set email alerts
|

Ductal breast carcinoma develops through different patterns of chromosomal evolution

Abstract: In a previous study that used comparative genomic hybridization (CGH) to analyze 43 ductal breast carcinomas selected for hyperdiploidy, we proposed the existence of two distinct pathways of chromosomal evolution. In the present study, in which we reassessed our cytogenetic findings on 158 ductal breast carcinomas selected for having a modal number of chromosomes of fewer than 60, we confirmed the existence of two subtypes of tumors. Along with the great majority of tumors (142 of 158) that evolved through str… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

1
1
0

Year Published

2005
2005
2015
2015

Publication Types

Select...
3
2

Relationship

1
4

Authors

Journals

citations
Cited by 5 publications
(2 citation statements)
references
References 19 publications
1
1
0
Order By: Relevance
“…Using ERBB2 status as a major discriminating factor for poorly differentiated IDC‐NOS, we made an interesting observation: CESH yielded more expression variation between poorly differentiated ERBB2 ‐positive and grade‐matched ERBB2 ‐negative IDC‐NOS than between ductal and lobular carcinoma (5 versus 3 at 95% CL/4 versus 2 at 99% CL). These findings strengthen the hypothesis that IDC‐NOS, even within‐grade, is a heterogeneous group of diseases exhibiting various genetically discernible subgroups 35. We could further establish an ERBB2 expression signature comprising four chromosomal regions that were up‐regulated in node‐negative, ERBB2 ‐positive IDC‐NOS: 3q24–q26.3, 14q24–q31, 17q12, and 20q12–q13.1 (95% CL).…”
Section: Discussionsupporting
confidence: 79%
“…Using ERBB2 status as a major discriminating factor for poorly differentiated IDC‐NOS, we made an interesting observation: CESH yielded more expression variation between poorly differentiated ERBB2 ‐positive and grade‐matched ERBB2 ‐negative IDC‐NOS than between ductal and lobular carcinoma (5 versus 3 at 95% CL/4 versus 2 at 99% CL). These findings strengthen the hypothesis that IDC‐NOS, even within‐grade, is a heterogeneous group of diseases exhibiting various genetically discernible subgroups 35. We could further establish an ERBB2 expression signature comprising four chromosomal regions that were up‐regulated in node‐negative, ERBB2 ‐positive IDC‐NOS: 3q24–q26.3, 14q24–q31, 17q12, and 20q12–q13.1 (95% CL).…”
Section: Discussionsupporting
confidence: 79%
“…For example, close to 50 cases of acute lymphoblastic leukemias (ALL), many of which of T-cell lineage, with +8 as the single anomaly have been published, and some solid tumor types/lesions, in particular desmoid tumors and Dupuytren's contracture, are also characterized by this abnormality [16][17][18]. Trisomy 8 is also common together with other chromosomal aberrations in a large number of tumor types, such as colon, breast, and head and neck cancer [19][20][21], Wilms tumor [22], and hepatoblastoma [23].…”
Section: Epidemiologymentioning
confidence: 99%